Cargando…

Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei

BACKGROUND: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei (PMP) is associated with excessive bleeding and acquired fibrinogen deficiency. Maintaining plasma fibrinogen may support hemostasis. OBJECTIVES: To compare hemostatic efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Ashok, Stanford, Sophia, Nunn, Sean, Alves, Sue, Sargant, Nigel, Rangarajan, Savita, Smith, Emily Arbuthnot, Bell, John, Dayal, Sanjeev, Cecil, Tom, Tzivanakis, Alexios, Kruzhkova, Irina, Solomon, Cristina, Knaub, Sigurd, Moran, Brendan, Mohamed, Faheez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	HAEMOSTASIS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027898/ https://www.ncbi.nlm.nih.gov/pubmed/31654548 http://dx.doi.org/10.1111/jth.14665

Ejemplares similares

Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study
por: Roy, Ashok, et al.
Publicado: (2023)

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients
por: Lissitchkov, Toshko, et al.
Publicado: (2020)

Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
por: Campanati, Renato Gomes, et al.
Publicado: (2014)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015)

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018)

Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin
por: Esquivel, Jesus, et al.
Publicado: (2012)

Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei
por: Solanki, Sohan Lal, et al.
Publicado: (2019)

A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei
por: Yamanaka, Kenya, et al.
Publicado: (2021)

Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009)

Quality of Life Study following Cytoreductive Surgery and Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei including Redo Procedures
por: Kirby, Rachel, et al.
Publicado: (2013)

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
por: Trilling, Bertrand, et al.
Publicado: (2021)

Anesthetic management for cytoreductive surgery of pseudomyxoma peritonei with high intra-abdominal pressure: A case report
por: Lin, Yan-Jun, et al.
Publicado: (2023)

Fibrinogen αC‐regions are not directly involved in fibrin polymerization as evidenced by a “Double‐Detroit” recombinant fibrinogen mutant and knobs‐mimic peptides
por: Duval, Cédric, et al.
Publicado: (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2018)

Prognosis for Young Females with Pseudomyxoma Peritonei of Appendiceal Origin and Unilateral or Bilateral Ovaries Preserved During Cytoreductive Surgery
por: Fu, Fengxian, et al.
Publicado: (2022)

Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
por: Zhao, Xin, et al.
Publicado: (2022)

First Report With Medium-term Follow-up of Intestinal Transplantation for Advanced and Recurrent Nonresectable Pseudomyxoma Peritonei
por: Reddy, Srikanth, et al.
Publicado: (2023)

Approach to pseudomyxoma peritonei
por: Rizvi, Syed Ali, et al.
Publicado: (2018)

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
por: Flatmark, Kjersti, et al.
Publicado: (2020)

Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei
por: Sørensen, Olaf, et al.
Publicado: (2019)

Determinants of Outcome with Reoperative Surgery for Pseudomyxoma Peritonei in 186 Patients
por: Sugarbaker, Paul H., et al.
Publicado: (2023)

Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
por: Patrick-Brown, Thale Dawn J. H., et al.
Publicado: (2020)

Pseudomyxoma peritonei: An uncommon tumor
por: Gupta, Surabhi, et al.
Publicado: (2010)

Huge and Unique Pseudomyxoma Peritonei
por: Tjokroprawiro, Brahmana Askandar, et al.
Publicado: (2021)

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
por: Santullo, Francesco, et al.
Publicado: (2021)

Ultrasound for Preoperatively Predicting Pathology Grade, Complete Cytoreduction Possibility, and Survival Outcomes of Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia
por: Djambas Khayat, Claudia, et al.
Publicado: (2022)

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)

Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms
por: van Eden, W. J., et al.
Publicado: (2019)

Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review
por: Floriano, Idevaldo, et al.
Publicado: (2022)

Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei
por: Patrick-Brown, Thale D.J.H., et al.
Publicado: (2023)

PSEUDOMYXOMA PERITONEI PRESENTING AS INGUINAL HERNIA
por: Campbell, Patrick, et al.
Publicado: (2009)

Pulmonary Metastasis from Pseudomyxoma Peritonei
por: Kitai, Toshiyuki
Publicado: (2012)

Clinicopathological features and prognosis of pseudomyxoma peritonei
por: WANG, HUAN, et al.
Publicado: (2014)

Novel Perspectives in Pseudomyxoma Peritonei Treatment
por: Sommariva, Antonio, et al.
Publicado: (2021)

Efficacy of pro‐ and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery
por: Bos, Sarah, et al.
Publicado: (2020)

Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy
por: Tzivanakis, A., et al.
Publicado: (2018)

Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel
por: Rauwerdink, Paulien, et al.
Publicado: (2022)

Recurrent Incisional Hernia due to Pseudomyxoma Peritonei
por: Ergul, Zafer, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o80qs6egt3kt2u226dq3bf5npr